Kailera Therapeutics Inc.
KLRA | NASDAQ
$12.86
-$0.55 (-4.10%)
At close: Oct 30, 2026, 4:00 PM ET
$12.86
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Revenue | n/a |
Cost of Revenue | n/a |
Gross Profit | n/a |
Operating Income | -158.34M |
Interest Income | 11.05M |
Pretax Income | -148.96M |
Net Income | -148.96M |
Selling & General & Admin | 49.23M |
Research & Development | 109.11M |
Other Expenses | n/a |
Operating Expenses | 158.34M |
Interest Expense | n/a |
Selling & Marketing Expenses | n/a |
Cost & Expenses | 158.34M |
Income Tax Expense | n/a |
Shares Outstanding (Basic) | 117.95M |
Shares Outstanding (Diluted) | 117.95M |
EPS (Basic) | -1.26 |
EPS (Diluted) | -1.26 |
EBITDA | -158.03M |
EBIT | -158.34M |
Depreciation & Amortization | 310K |
Add to Watchlist
Select watchlists to add or remove KLRA